Ocular surface disorders associated with the use of dupilumab based on WHO VigiBase
Abstract Dupilumab is a dual inhibitor of interleukin-4 and interleukin-13 and is mainly used to treat moderate-to-severe atopic dermatitis. Post-marketing safety data related to dupilumab have been accumulated, and it has been found that ocular surface diseases are closely associated with dupilumab...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/91b553811e6f4579b0f1c7d94711a33c |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|